PCK 8.82% 3.1¢ painchek ltd

Ann: Appendix 4C - quarterly, page-12

  1. 338 Posts.
    lightbulb Created with Sketch. 52
    In summary, PainChek® has evolved from a conceptual healthcare product to a market reality with strong sales and customer satisfaction in less than 2 years. This outstanding achievement has been accomplished with minimal investment. We are addressing large untapped global markets with a business model that is sustainable, low cost and scalable. In addition, we have the core technology, patents and trademarks to protect our unique position, a pipeline of new products and a team that can execute the global strategy. Tick tock
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.1¢
Change
-0.003(8.82%)
Mkt cap ! $55.61M
Open High Low Value Volume
3.4¢ 3.4¢ 3.1¢ $9.355K 290.8K

Buyers (Bids)

No. Vol. Price($)
1 58934 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 122 1
View Market Depth
Last trade - 10.19am 12/09/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.